Arterial hypertension (AHT) is the most important modifiable risk factor for cardiovascular, cerebrovascular and renal disease due to its high prevalence and the associated morbidity and mortality.
Arterial hypertension (AHT) is the most important modifiable risk factor for cardiovascular, cerebrovascular and renal disease due to its high prevalence and the associated morbidity and mortality. 1 There is a high variability of AHT prevalence in adults worldwide, as has been described by a systematic review, with the highest prevalence reported in Poland (68.9% in men and 72.5% in women) and the lowest in rural India (3.4% in men and 6.8% in women). 1 These numbers stand in contrast to prevalence rates reported in a recent meta-analysis specifically examining AHT prevalence in India. 2 They report a prevalence of 25% for rural Indians. 2 In children, AHT prevalence rates for European countries have been reported to be between 2% and 13%. 3 For Indian schoolchildren, previous studies reported prevalence rates between 2% and 11%. 4 Contrary to the above mentioned numbers, Narang et al. describe in their paper entitled 'Prevalence and determinants of hypertension in apparently healthy schoolchildren in India: A multi-center study' that 23% of apparently healthy schoolchildren in rural India were found to have AHT.
5 Surprisingly, AHT prevalence was not only very high in overweight children, but is also in children with a normal body weight, with 20% of these children affected. 5 This finding is rather surprising as previously, regarding children with a normal body weight, AHT has been described, for example, in 1.4% of normal weight adolescents. 3 One could expect that such an increase of AHT prevalence would translate into an immense increase of the prevalence of cardiovascular, cerebrovascular and renal disease in a few years' time, which would accordingly burden the health care system and stretch its budget. We are very much aware of such correlations for adults, but does this apply to children as well? This leads to the question of how AHT is defined in children and adolescents.
Contrary to in adults, the definition of AHT in children is based on the normal distribution of blood pressure (BP) in healthy children, and not on the cardiovascular morbidity and mortality associated with a certain level of BP. 3 As AHT in children is defined by BP values greater than the 95th percentile, we would expect an AHT prevalence of 5%. 3 A measured AHT prevalence of more than 5% can be expected in two potential scenarios: a) the true AHT prevalence is indeed higher than 5%, ergo the percentiles are outdated; or b) the true AHT prevalence would be 5%, but has been overestimated, for example due to methodology such as blood pressure measurement (BPM) procedure or a selection bias.
Scenario a) could be caused by changes of lifestyle, such as an increased prevalence of obesity, or genetic background, which may vary locally. 3, 6 The influence of genetics on BP values in children has recently been studied: Jansen et al. demonstrated an association between higher systolic BP with a higher genetic risk score, but only when BP was measured in a supine but not a sitting position. 6 As a reason for this, they postulated that sitting BP is more influenced by factors such as body size, thus rather reflecting lifestyle, whereas supine BP might better reflect innate BP values predominantly driven by genes. 6 As Narang et al. measured BP in a sitting position, their result, if indicating a true increase in AHT prevalence, probably reflects lifestyle rather than genetics. 5 Scenario a) also includes the question of how well the percentiles correlate with the cardiovascular risk. To date, there is no direct evidence that screening for AHT in children and adolescents reduces adverse cardiovascular outcomes in adults, which does not mean there is no impact, but simply that it has not been examined to date. 7 Despite this, there are limited data that treatment of AHT in children induces regression of left ventricular hypertrophy, ameliorates cardiac geometry and function and is nephroprotective. Scenario b) could be caused by an inadequate BPM procedure, which leads to a misclassification, that is, children with white-coat hypertension could be identified as 'hypertensive'. With the 75th and 95th percentile of BPM often being 1 to 2 mmHg apart, correct assessment of BP is crucial. 3 The European guidelines recommend measuring BP three times after sitting for 3-5 min and using the average of the last two readings. 3 Whitecoat hypertension (1-44%) and masked hypertension (10%) are phenomena frequently encountered.
3 Lower AHT prevalence rates are usually reported with 2-3 measurements taken, 1 which could be explained by short-term white-coat hypertension, that is, normalisation of an initially elevated BP after several BPMs. 8 The above mentioned meta-analysis reporting higher prevalence rates in rural India does not comment on BPM methods, 2 which leads to the suspicion, that no stringent BPM protocol was applied with a certain risk of BP overestimation, due to the high prevalence of whitecoat hypertension. Short-term white-coat hypertension, which has been described in 34-58% of BPMs, depending on the definition, 9 is not the only BP pattern encountered at sessions including several measurements. BP may also increase during repeated measurements, as seen in 16-32%. 9 Narang et al. used a single BPM, which was repeated once only if the first BPM was elevated, for this present study. 5 Previous calculations suggested that for an accurate assessment of BP in children, 4-5 BPMs would be useful with oscillometric devices. 10 Therefore, to determine whether the stated numbers are an over-or even under-estimation of the actual AHT prevalence based on the present data is impossible.
The conclusion to draw out of the paper by Narang et al. is that we need to raise awareness of a possibly higher AHT prevalence than expected in both normal weight and overweight children. However, we need studies to estimate the correlation of BP values with cardiovascular risk in order to prevent false labelling of AHT, as the diagnosis by itself can lead to a reduced quality of life, for example through increased anxiety, symptoms of depression and perception of ill-health, and may have a socio-economic impact with increased absenteeism not explainable through treatment or AHT-associated morbidity. 11 We have to find ways to successfully screen children without an over-diagnosis. This topic needs further attention.
